T1	Participants 56 112	patients affected by acne and polycystic ovary syndrome:
T2	Participants 313 343	few patients, especially women
T3	Participants 503 572	In women with acne and proven PCOS therapy with estroprogestins (EPs)
T4	Participants 886 961	women affected by mild to severe acne and polycystic ovary syndrome (PCOS).
T5	Participants 970 1002	Fifty-nine women were randomized
T6	Participants 1612 1627	women with acne
